Alport syndrome: facts and opinions [version 1; referees: 2 approved]
In this commentary, I review recent advances in Alport syndrome genetics, diagnostics, and therapeutics. I also offer some opinions regarding strategies to optimize the early identification of affected individuals to promote early therapeutic intervention.
Main Author: | Clifford Kashtan |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2017-01-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | https://f1000research.com/articles/6-50/v1 |
Similar Items
-
C3 glomerulopathy [version 1; referees: 4 approved]
by: H. Terence Cook
Published: (2017-03-01) -
Cell biology and genetics of minimal change disease [version 1; referees: 2 approved]
by: Moin A. Saleem, et al.
Published: (2016-03-01) -
Autosomal dominant polycystic kidney disease: recent advances in clinical management [version 1; referees: 2 approved]
by: Zhiguo Mao, et al.
Published: (2016-08-01) -
Recent advances in managing and understanding enuresis [version 1; referees: 2 approved]
by: Charlotte Van Herzeele, et al.
Published: (2017-10-01) -
Recent advances in understanding and managing gout [version 1; referees: 2 approved]
by: Talia F. Igel, et al.
Published: (2017-03-01)